Targeting Mitochondrial Dysfunction: A Controlled Study on Novel Therapeutics for Metabolic Disorders
Keywords:
Mitochondrial dysfunction, Metabolic syndrome, Therapeutics, Clinical trial, Patient-reported outcomes, Bioenergetics, Health optimization, Energy metabolism, Oxidative stressAbstract
Mitochondrial dysfunction has emerged as a significant contributor to the pathophysiology of metabolic disorders, impacting energy homeostasis and leading to heightened disease prevalence. This study investigates the efficacy of novel therapeutic agents targeting mitochondrial pathways in a controlled clinical trial involving 150 participants diagnosed with metabolic syndrome. Utilizing a randomized, double-blind methodology over a 12-week period, we assessed metabolic parameters, mitochondrial function, and patient-reported outcomes. Statistical analyses were performed using SPSS v25, with p-values < 0.05 indicating significance. Results demonstrated a statistically significant improvement in mitochondrial bioenergetics and metabolic profiles in the treatment group compared to placebo, suggesting that targeted mitochondrial therapies may offer a promising intervention for metabolic disorders. Our findings underscore the importance of mitochondrial health in managing metabolic syndromes and highlight potential avenues for further research in this domain.
References
Mavuri, M., Chakrabarty, S., Rathod, U., & Sarda, D. (2025, December). Geospatial Analysis Using Transformer on TOAR and Meteorological Data for Early Warning of Particulate Matter Exceedance. In 2025 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) (pp. 7036-7043). IEEE.
